Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

tais-med.com Blueprint · Rev.39

Sheet A · Product board

5-amino-1mq and cd38 inhibitor — 50mg | NNMT (NAD+ Axis) Size:16oz Glass Bottle Treat anemia genetic testing before 5

Unit price

USD26.53

USD47.53

Pay in 4 interest-free payments of $6.63 Learn more

Field rating

4.9

Verified studio score · Spec revision current

Fit · Size

5-amino-1mq and cd38 inhibitor

5-amino-1mq and cd38 inhibitor — 50mg | NNMT (NAD+ Axis) Size:16oz Glass Bottle Treat anemia genetic testing before 5

SKU: 62704636981

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 19 - Oct 24

Description

5-amino-1mq and cd38 inhibitor — 50mg | NNMT (NAD+ Axis) Size:16oz Glass Bottle Treat anemia genetic testing before 5

genetic testing before 5 amino 1mq supplement 5-AMINO-1MQ VIAL (5MG) 5-Amino -1MQ – High Purity 5 –

Regular injections can provide sustained benefits

Treat anemia

Size:16oz Glass Bottle

By blocking NNMT, 5-Amino-1MQ helps increase cellular NAD+ levels, supporting mitochondrial function, metabolic efficiency, and energy production

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

FDA Panel Backs Six Popular Peptides for Pharmacy Use, but They Are Not Approved Yet

FDA Panel Backs Six Popular Peptides for Pharmacy Use, but They Are Not Approved Yet

US$ 23.03

4.6 (17 reviews)

Big news for the peptide space., The FDA Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to

Big news for the peptide space., The FDA Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to

US$ 26.02

4.4 (10 reviews)

bpc-157 safety regulatory status fda warning bpc 157 compounded peptide FDA to Convene Expert Panel bpc-157 fda approval status human –

bpc-157 safety regulatory status fda warning bpc 157 compounded peptide FDA to Convene Expert Panel bpc-157 fda approval status human –

US$ 25.98

4.0 (23 reviews)

FDA panel votes to place popular peptide BPC-157 on compounding list

FDA panel votes to place popular peptide BPC-157 on compounding list

US$ 23.08

4.7 (18 reviews)

fda bpc-157 approval status human use compounding peptides warning unapproved Big FDA review coming this July. Here's what athletes and BPC-157 FDA Should the FDA ease restrictions –

fda bpc-157 approval status human use compounding peptides warning unapproved Big FDA review coming this July. Here's what athletes and BPC-157 FDA Should the FDA ease restrictions –

US$ 20.19

4.4 (18 reviews)

Is BPC-157 FDA Approved? The July 2026 Vote

Is BPC-157 FDA Approved? The July 2026 Vote

US$ 28.00

4.5 (24 reviews)

An FDA Panel Just Voted to Widen Access to Peptides. Here's What It Actually Means for the Longevity Space

An FDA Panel Just Voted to Widen Access to Peptides. Here's What It Actually Means for the Longevity Space

US$ 29.03

4.9 (23 reviews)

The Truth About Peptides, Compounding Pharmacies, and FDA Regulation

The Truth About Peptides, Compounding Pharmacies, and FDA Regulation

US$ 28.28

4.2 (29 reviews)

⚠️ Warning: BPC-157 is a synthetic peptide and an unapproved drug, often promoted with misleading claims. It is prohibited and on the DoD Prohibited Dietary Supplement Ingredients List. Don't gamble with your

⚠️ Warning: BPC-157 is a synthetic peptide and an unapproved drug, often promoted with misleading claims. It is prohibited and on the DoD Prohibited Dietary Supplement Ingredients List. Don't gamble with your

US$ 26.48

4.3 (30 reviews)

FDA Panel Recommends Compounding Unapproved Peptides

FDA Panel Recommends Compounding Unapproved Peptides

US$ 26.15

4.1 (29 reviews)

FDA Peptide Compounding Vote 2026: What It Means

FDA Peptide Compounding Vote 2026: What It Means

US$ 25.82

4.5 (15 reviews)

Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides – Holt Law

Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides – Holt Law

US$ 27.72

4.9 (19 reviews)

bpc-157 fda approval status human use compounding peptides warning unapproved Big FDA review coming this July. Here's what athletes and BPC-157 FDA Status: Is – NBC News

bpc-157 fda approval status human use compounding peptides warning unapproved Big FDA review coming this July. Here's what athletes and BPC-157 FDA Status: Is – NBC News

US$ 28.55

4.7 (16 reviews)

Did the FDA Approve BPC-157? Not So Fast

Did the FDA Approve BPC-157? Not So Fast

US$ 27.07

4.0 (5 reviews)

FDA July 2026 Peptide Meeting: Approval, Access & Safety

FDA July 2026 Peptide Meeting: Approval, Access & Safety

US$ 28.46

4.4 (20 reviews)

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

US$ 23.60

4.6 (17 reviews)

FDA Committee Recommends BPC-157 Approval | The Precision Peptide Company posted on the topic

FDA Committee Recommends BPC-157 Approval | The Precision Peptide Company posted on the topic

US$ 21.56

4.9 (25 reviews)

fda approved bpc 157 bpc-157 warning not human use peptide Public advisory aka Wolverine. This peptide – FDA advisory committee votes to – bpc-157 fda approval status safety –

fda approved bpc 157 bpc-157 warning not human use peptide Public advisory aka Wolverine. This peptide – FDA advisory committee votes to – bpc-157 fda approval status safety –

US$ 26.81

4.1 (21 reviews)

Peptide news worth paying attention to. The FDA's Pharmacy Compounding Advisory Committee just voted YES to recommend BPC-157, TB-500, KPV, and MOTS-c for the 503A compounding list. This isn't FDA approval. That

Peptide news worth paying attention to. The FDA's Pharmacy Compounding Advisory Committee just voted YES to recommend BPC-157, TB-500, KPV, and MOTS-c for the 503A compounding list. This isn't FDA approval. That

US$ 27.04

5.0 (18 reviews)

FDA's July 23 Peptide Panel Backed BPC-157, KPV, and TB-500. Here Is What Happens Next. | PeptIQ Blog

FDA's July 23 Peptide Panel Backed BPC-157, KPV, and TB-500. Here Is What Happens Next. | PeptIQ Blog

US$ 24.14

4.7 (15 reviews)